1 Epidemiology of Pancreatic Neuroendocrine Tumours.- 2 Quality of Life Issues Identified by Healthcare Workers and Patients with Metastatic Carcinoid/Neuroendocrine Tumours.- 3 Diagnosis and Localisation of Insulinoma.- 4 GI Hormone Producing Tumours: Syndromes and Treatment Options.- 5 Progress by Collaboration: ESPAC Studies.- 6 Gemcitabine: a Systematic Review.- 7 Farnesyl Protein Transferase Inhibitors in Pancreatic Cancer.- 8 Novel Alternatives to Chemotherapy in Advanced Disease: Gastrin Antibodies.- 9 Novel Alternatives to Chemotherapy in Advanced Disease: Gene Transfer.- 10 Suicide Gene Therapy for Pancreatic Cancer.- 11 Pancreatic Cystic Lesions and Neoplasms.- 12 Pancreatic Involvement in Von Hippel-Lindau Disease.- 13 Intraductal Papillary Mucinous Tumours of the Pancreas.- 14 Endoscopic Ultrasound in the Diagnosis of Chronic Pancreatitis and Pancreatic Cancer.- 15 Natural Course of Chronic Pancreatitis.- 16 Autoimmune Pancreatitis.- 17 What’s New in Pancreatic Stellate Cell Biology?.- 18 Pancreatic Stellate Cells and their Role in Fibrogenesis.- 19 Factors Influencing Pancreatic Stellate Cell Phenotype and Cell Turnover.- 20 Acinar-Islet Cell Interactions: Diabetes Mellitus in Chronic Pancreatitis.- 21 Acinar-Islet Interactions: Pancreatic Exocrine Insufficiency in Diabetes Mellitus.- 22 Genetic Basis of Hereditary and Sporadic Pancreatitis.- 23 Cytokines in Chronic Pancreatitis.- 24 Cytokine Gene Polymorphisms in Acute Pancreatitis.- 25 Genetic Polymorphism, the Immune Response and Chronic Pancreatitis.- 26 Xenobiotic Metabolising Enzymes in Pancreatitis.- 27 Trypsin Activation and Inhibition in Pancreatitis.- 28 Selecting Patients for Trials and Treatment: Apache-II?.- 29 Selecting Severe Cases of Acute Pancreatitis for Trials and for Treatment: Enzymesand Activation Peptides.- 30 Selecting Severe Cases of Acute Pancreatitis on the Basis of Organ Failure.- 31 Individual Features Related to Severity in Acute Pancreatitis.- 32 Sterile Necrosis in Acute Necrotizing Pancreatitis: Current Concepts and Management Strategies.- 33 Management of Infected Pancreatic Necrosis.- 34 Antibiotics in Acute Pancreatitis.- 35 Enteral Nutrition in Acute Pancreatitis: Mucosal Barrier.- 36 Early Enteral Nutrition and Markers of the Inflammatory Response in Severe Acute Pancreatitis.- 37 Enteral Nutrition in Acute Pancreatitis: Clinical Outcome.- 38 Measurement of Symptoms and Quality of Life in Pancreatic Disease.- 39 Mechanism of Nociception in Chronic Pancreatitis.- 40 Bilateral Thoracoscopic Splanchnicectomy in the Management of Pain in Patients with Chronic Pancreatitis.- 41 Nerve Pathways for Pain.- 42 Pain Management in Chronic Pancreatitis.- 43 Pancreatic Decompression in Chronic Pancreatitis.

GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com